Citigroup’s NeuBase Therapeutics, Inc. Common Stock NBSE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Hold |
0
| – | – | – | 5580 |
|
|
2021
Q2 | – | Sell |
-56
| Closed | -$8K | – | 5693 |
|
|
2021
Q1 | $8K | Sell |
56
-106
| -65% | -$15.1K | ﹤0.01% | 5112 |
|
|
2020
Q4 | $23K | Buy |
162
+122
| +305% | +$17.3K | ﹤0.01% | 4563 |
|
|
2020
Q3 | $6K | Sell |
40
-76
| -66% | -$11.4K | ﹤0.01% | 4598 |
|
|
2020
Q2 | $20K | Buy |
116
+67
| +137% | +$11.6K | ﹤0.01% | 4268 |
|
|
2020
Q1 | $7K | Buy |
+49
| New | +$7K | ﹤0.01% | 4749 |
|
|
2016
Q1 | – | Hold |
0
| – | -$1K | – | 5662 |
|
|
2015
Q4 | – | Sell |
-4
| Closed | -$4K | – | 5296 |
|
|
2015
Q3 | $4K | Hold |
4
| – | – | ﹤0.01% | 4742 |
|
|
2015
Q2 | $4K | Sell |
4
-3
| -43% | -$3K | ﹤0.01% | 4980 |
|
|
2015
Q1 | $7K | Sell |
7
-2
| -22% | -$2K | ﹤0.01% | 4916 |
|
|
2014
Q4 | $31K | Buy |
9
+7
| +350% | +$24.1K | ﹤0.01% | 4375 |
|
|
2014
Q3 | $5K | Buy |
+2
| New | +$5K | ﹤0.01% | 4930 |
|
|
2014
Q2 | – | Sell |
-3
| Closed | -$15K | – | 5148 |
|
|
2014
Q1 | $15K | Buy |
+3
| New | +$15K | ﹤0.01% | 4640 |
|